38128-86-8 Usage
Uses
Used in Pharmaceutical Research:
(8E,14E,24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-8-[(2-phenylethoxy)amino]methylidene-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate is used as a compound of interest for pharmaceutical research due to its complex structure and potential for biological activity.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, (8E,14E,24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-8-{[(2-phenylethoxy)amino]methylidene}-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate is used as a starting point for the development of new drugs, given its unique structural features that may interact with biological targets in novel ways.
Used in Chemical Synthesis:
(8E,14E,24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-8-[(2-phenylethoxy)amino]methylidene-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate may also be utilized in chemical synthesis as a precursor to other complex molecules, taking advantage of its various functional groups for further reactions and modifications.
Check Digit Verification of cas no
The CAS Registry Mumber 38128-86-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,1,2 and 8 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 38128-86:
(7*3)+(6*8)+(5*1)+(4*2)+(3*8)+(2*8)+(1*6)=128
128 % 10 = 8
So 38128-86-8 is a valid CAS Registry Number.
38128-86-8Relevant academic research and scientific papers
Oximes of 3 formylrifamycin SV. Synthesis, antibacterial activity, and other biological properties
Cricchio,Lancini,Tamborini,Sensi
, p. 396 - 403 (2007/10/06)
The synthesis of the oximes of 3 formylrifamycin SV and the preparation of some of the O substituted hydroxylamine intermediates are described. The chemical and physical characteristics, the antibacterial activity on wild type and rifampicin resistant strains, and other biological properties of the new derivatives are reported. Structure activity relationships show that increasing the lipophilicity of the oxime substituent decreases the antibacterial activity, both in vitro and in experimental infection, whereas inhibition of a rifampicin resistant strain of S. aureus and of several transcribing enzymes is increased.
